APO Research
Talk to an analyst

APO RESEARCH · REPORT

γ-Aminobutyric Acid Receptor Agonists

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global γ-Aminobutyric Acid Receptor Agonists Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025190 pages

Choose your research edition.

Industry Researchγ-Aminobutyric Acid Receptor Agonists Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal γ-Aminobutyric Acid Receptor Agonists Industry Growth and Trends Forecast to 2032128 pages · $3,450 USDMarket StructureGlobal γ-Aminobutyric Acid Receptor Agonists Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal γ-Aminobutyric Acid Receptor Agonists Market Outlook and Growth Opportunities 2026219 pages · $4,250 USDMarket Analysis & ForecastGlobal γ-Aminobutyric Acid Receptor Agonists Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global γ-Aminobutyric Acid Receptor Agonists market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for γ-Aminobutyric Acid Receptor Agonists is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for γ-Aminobutyric Acid Receptor Agonists is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for γ-Aminobutyric Acid Receptor Agonists is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for γ-Aminobutyric Acid Receptor Agonists is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of γ-Aminobutyric Acid Receptor Agonists include Akorn, Apotex, CHEPLAPHARM, Hikma, Jazz Pharmaceuicals, Neurelis, SAGE Therapeutics, Sandoz and Torrent Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global γ-Aminobutyric Acid Receptor Agonists market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of γ-Aminobutyric Acid Receptor Agonists and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents γ-Aminobutyric Acid Receptor Agonists sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the γ-Aminobutyric Acid Receptor Agonists market size, projected growth trends, production technologies, key applications, and end-use industries.

γ-Aminobutyric Acid Receptor Agonists Segment by Company

Akorn

Apotex

CHEPLAPHARM

Hikma

Jazz Pharmaceuicals

Neurelis

SAGE Therapeutics

Sandoz

Torrent Pharma

Viatris

WG Critical Care

AstraZeneca

Changzhou Siyao Pharmaceutical

Fresenius Kabi

GSK

Sichuan HaiscoPharmaceuical

Huazhong Pharmaceutical

Pfizer

Roche

Mylan

Novartis

Sanofi

Shanghai Pharmaceuticals Holding

Sun Pharma

Teva

Takeda

γ-Aminobutyric Acid Receptor Agonists Segment by Type

GABAA Receptors

GABAB Receptors

GABAC Receptors

γ-Aminobutyric Acid Receptor Agonists Segment by Application

Epilepsy

Anxiety

Neuropathic Pain

Insomnia

Other

γ-Aminobutyric Acid Receptor Agonists Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global γ-Aminobutyric Acid Receptor Agonists market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of γ-Aminobutyric Acid Receptor Agonists and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of γ-Aminobutyric Acid Receptor Agonists.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the γ-Aminobutyric Acid Receptor Agonists market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of γ-Aminobutyric Acid Receptor Agonists manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of γ-Aminobutyric Acid Receptor Agonists in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of γ-Aminobutyric Acid Receptor Agonists in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. γ-Aminobutyric Acid Receptor Agonists Industry Trends Table 2. γ-Aminobutyric Acid Receptor Agonists Industry Drivers Table 3. γ-Aminobutyric Acid Receptor Agonists Industry Opportunities and Challenges Table 4. γ-Aminobutyric Acid Receptor Agonists Industry Restraints Table 5. Global γ-Aminobutyric Acid Receptor Agonists Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Manufacturers (2021-2026) Table 7. Global γ-Aminobutyric Acid Receptor Agonists Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Manufacturers Table 9. Global γ-Aminobutyric Acid Receptor Agonists Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global γ-Aminobutyric Acid Receptor Agonists Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global γ-Aminobutyric Acid Receptor Agonists Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global γ-Aminobutyric Acid Receptor Agonists Manufacturers, Product Type & Application Table 13. Global γ-Aminobutyric Acid Receptor Agonists Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global γ-Aminobutyric Acid Receptor Agonists by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of GABAA Receptors Table 17. Major Manufacturers of GABAB Receptors Table 18. Major Manufacturers of GABAC Receptors Table 19. Global γ-Aminobutyric Acid Receptor Agonists Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global γ-Aminobutyric Acid Receptor Agonists Sales by Type (2021-2026) & (K Units) Table 21. Global γ-Aminobutyric Acid Receptor Agonists Sales by Type (2027-2032) & (K Units) Table 22. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Type (2021-2026) Table 23. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Type (2027-2032) Table 24. Global γ-Aminobutyric Acid Receptor Agonists Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global γ-Aminobutyric Acid Receptor Agonists Revenue by Type (2021-2026) & (K Units) Table 26. Global γ-Aminobutyric Acid Receptor Agonists Revenue by Type (2027-2032) & (K Units) Table 27. Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Type (2021-2026) Table 28. Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Epilepsy Table 30. Major Manufacturers of Anxiety Table 31. Major Manufacturers of Neuropathic Pain Table 32. Major Manufacturers of Insomnia Table 33. Major Manufacturers of Other Table 34. Global γ-Aminobutyric Acid Receptor Agonists Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global γ-Aminobutyric Acid Receptor Agonists Sales by Application (2021-2026) & (K Units) Table 36. Global γ-Aminobutyric Acid Receptor Agonists Sales by Application (2027-2032) & (K Units) Table 37. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Application (2021-2026) Table 38. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Application (2027-2032) Table 39. Global γ-Aminobutyric Acid Receptor Agonists Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global γ-Aminobutyric Acid Receptor Agonists Revenue by Application (2021-2026) & (K Units) Table 41. Global γ-Aminobutyric Acid Receptor Agonists Revenue by Application (2027-2032) & (K Units) Table 42. Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Application (2021-2026) Table 43. Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Application (2027-2032) Table 44. Global γ-Aminobutyric Acid Receptor Agonists Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global γ-Aminobutyric Acid Receptor Agonists Sales by Region (2021-2026) & (K Units) Table 46. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Region (2021-2026) Table 47. Global γ-Aminobutyric Acid Receptor Agonists Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global γ-Aminobutyric Acid Receptor Agonists Sales Forecasted Market Share by Region (2027-2032) Table 49. North America γ-Aminobutyric Acid Receptor Agonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America γ-Aminobutyric Acid Receptor Agonists Sales by Country (2021-2026) & (K Units) Table 51. North America γ-Aminobutyric Acid Receptor Agonists Sales by Country (2027-2032) & (K Units) Table 52. Europe γ-Aminobutyric Acid Receptor Agonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe γ-Aminobutyric Acid Receptor Agonists Sales by Country (2021-2026) & (K Units) Table 54. Europe γ-Aminobutyric Acid Receptor Agonists Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific γ-Aminobutyric Acid Receptor Agonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific γ-Aminobutyric Acid Receptor Agonists Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific γ-Aminobutyric Acid Receptor Agonists Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Sales by Country (2027-2032) & (K Units) Table 61. Global γ-Aminobutyric Acid Receptor Agonists Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global γ-Aminobutyric Acid Receptor Agonists Revenue by Region (2021-2026) & (US$ Million) Table 63. Global γ-Aminobutyric Acid Receptor Agonists Revenue by Region (2027-2032) & (US$ Million) Table 64. Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Region (2021-2026) Table 65. Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Region (2027-2032) Table 66. Akorn Company Information Table 67. Akorn Business Overview Table 68. Akorn γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Akorn γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 70. Akorn Recent Development Table 71. Apotex Company Information Table 72. Apotex Business Overview Table 73. Apotex γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Apotex γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 75. Apotex Recent Development Table 76. CHEPLAPHARM Company Information Table 77. CHEPLAPHARM Business Overview Table 78. CHEPLAPHARM γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. CHEPLAPHARM γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 80. CHEPLAPHARM Recent Development Table 81. Hikma Company Information Table 82. Hikma Business Overview Table 83. Hikma γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Hikma γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 85. Hikma Recent Development Table 86. Jazz Pharmaceuicals Company Information Table 87. Jazz Pharmaceuicals Business Overview Table 88. Jazz Pharmaceuicals γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Jazz Pharmaceuicals γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 90. Jazz Pharmaceuicals Recent Development Table 91. Neurelis Company Information Table 92. Neurelis Business Overview Table 93. Neurelis γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Neurelis γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 95. Neurelis Recent Development Table 96. SAGE Therapeutics Company Information Table 97. SAGE Therapeutics Business Overview Table 98. SAGE Therapeutics γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. SAGE Therapeutics γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 100. SAGE Therapeutics Recent Development Table 101. Sandoz Company Information Table 102. Sandoz Business Overview Table 103. Sandoz γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Sandoz γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 105. Sandoz Recent Development Table 106. Torrent Pharma Company Information Table 107. Torrent Pharma Business Overview Table 108. Torrent Pharma γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Torrent Pharma γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 110. Torrent Pharma Recent Development Table 111. Viatris Company Information Table 112. Viatris Business Overview Table 113. Viatris γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Viatris γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 115. Viatris Recent Development Table 116. WG Critical Care Company Information Table 117. WG Critical Care Business Overview Table 118. WG Critical Care γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. WG Critical Care γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 120. WG Critical Care Recent Development Table 121. AstraZeneca Company Information Table 122. AstraZeneca Business Overview Table 123. AstraZeneca γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. AstraZeneca γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 125. AstraZeneca Recent Development Table 126. Changzhou Siyao Pharmaceutical Company Information Table 127. Changzhou Siyao Pharmaceutical Business Overview Table 128. Changzhou Siyao Pharmaceutical γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Changzhou Siyao Pharmaceutical γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 130. Changzhou Siyao Pharmaceutical Recent Development Table 131. Fresenius Kabi Company Information Table 132. Fresenius Kabi Business Overview Table 133. Fresenius Kabi γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Fresenius Kabi γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 135. Fresenius Kabi Recent Development Table 136. GSK Company Information Table 137. GSK Business Overview Table 138. GSK γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 139. GSK γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 140. GSK Recent Development Table 141. Sichuan HaiscoPharmaceuical Company Information Table 142. Sichuan HaiscoPharmaceuical Business Overview Table 143. Sichuan HaiscoPharmaceuical γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 144. Sichuan HaiscoPharmaceuical γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 145. Sichuan HaiscoPharmaceuical Recent Development Table 146. Huazhong Pharmaceutical Company Information Table 147. Huazhong Pharmaceutical Business Overview Table 148. Huazhong Pharmaceutical γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 149. Huazhong Pharmaceutical γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 150. Huazhong Pharmaceutical Recent Development Table 151. Pfizer Company Information Table 152. Pfizer Business Overview Table 153. Pfizer γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 154. Pfizer γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 155. Pfizer Recent Development Table 156. Roche Company Information Table 157. Roche Business Overview Table 158. Roche γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 159. Roche γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 160. Roche Recent Development Table 161. Mylan Company Information Table 162. Mylan Business Overview Table 163. Mylan γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 164. Mylan γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 165. Mylan Recent Development Table 166. Novartis Company Information Table 167. Novartis Business Overview Table 168. Novartis γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 169. Novartis γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 170. Novartis Recent Development Table 171. Sanofi Company Information Table 172. Sanofi Business Overview Table 173. Sanofi γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 174. Sanofi γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 175. Sanofi Recent Development Table 176. Shanghai Pharmaceuticals Holding Company Information Table 177. Shanghai Pharmaceuticals Holding Business Overview Table 178. Shanghai Pharmaceuticals Holding γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 179. Shanghai Pharmaceuticals Holding γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 180. Shanghai Pharmaceuticals Holding Recent Development Table 181. Sun Pharma Company Information Table 182. Sun Pharma Business Overview Table 183. Sun Pharma γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 184. Sun Pharma γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 185. Sun Pharma Recent Development Table 186. Teva Company Information Table 187. Teva Business Overview Table 188. Teva γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 189. Teva γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 190. Teva Recent Development Table 191. Takeda Company Information Table 192. Takeda Business Overview Table 193. Takeda γ-Aminobutyric Acid Receptor Agonists Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 194. Takeda γ-Aminobutyric Acid Receptor Agonists Product Portfolio Table 195. Takeda Recent Development Table 196. Key Raw Materials Table 197. Raw Materials Key Suppliers Table 198. γ-Aminobutyric Acid Receptor Agonists Distributors List Table 199. γ-Aminobutyric Acid Receptor Agonists Customers List Table 200. Research Programs/Design for This Report Table 201. Authors List of This Report Table 202. Secondary Sources Table 203. Primary Sources List of Figures Figure 1. γ-Aminobutyric Acid Receptor Agonists Product Image Figure 2. Global γ-Aminobutyric Acid Receptor Agonists Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global γ-Aminobutyric Acid Receptor Agonists Market Size (2021-2032) & (US$ Million) Figure 4. Global γ-Aminobutyric Acid Receptor Agonists Sales (2021-2032) & (K Units) Figure 5. Global γ-Aminobutyric Acid Receptor Agonists Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 γ-Aminobutyric Acid Receptor Agonists Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. GABAA Receptors Image Figure 9. GABAB Receptors Image Figure 10. GABAC Receptors Image Figure 11. Global γ-Aminobutyric Acid Receptor Agonists Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Type (2021-2032) Figure 14. Global γ-Aminobutyric Acid Receptor Agonists Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Type (2021-2032) Figure 17. Epilepsy Image Figure 18. Anxiety Image Figure 19. Neuropathic Pain Image Figure 20. Insomnia Image Figure 21. Other Image Figure 22. Global γ-Aminobutyric Acid Receptor Agonists Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Application (2021-2032) Figure 25. Global γ-Aminobutyric Acid Receptor Agonists Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Application (2021-2032) Figure 28. North America γ-Aminobutyric Acid Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Country (2021-2032) Figure 30. U.S. γ-Aminobutyric Acid Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada γ-Aminobutyric Acid Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico γ-Aminobutyric Acid Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe γ-Aminobutyric Acid Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Country (2021-2032) Figure 35. Germany γ-Aminobutyric Acid Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France γ-Aminobutyric Acid Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. γ-Aminobutyric Acid Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy γ-Aminobutyric Acid Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands γ-Aminobutyric Acid Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific γ-Aminobutyric Acid Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Country (2021-2032) Figure 42. China γ-Aminobutyric Acid Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan γ-Aminobutyric Acid Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea γ-Aminobutyric Acid Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia γ-Aminobutyric Acid Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India γ-Aminobutyric Acid Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia γ-Aminobutyric Acid Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Country (2021-2032) Figure 50. Brazil γ-Aminobutyric Acid Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa γ-Aminobutyric Acid Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia γ-Aminobutyric Acid Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey γ-Aminobutyric Acid Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina γ-Aminobutyric Acid Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE γ-Aminobutyric Acid Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt γ-Aminobutyric Acid Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile γ-Aminobutyric Acid Receptor Agonists Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global γ-Aminobutyric Acid Receptor Agonists Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America γ-Aminobutyric Acid Receptor Agonists Revenue (2021-2032) & (US$ Million) Figure 61. North America γ-Aminobutyric Acid Receptor Agonists Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe γ-Aminobutyric Acid Receptor Agonists Revenue (2021-2032) & (US$ Million) Figure 63. Europe γ-Aminobutyric Acid Receptor Agonists Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific γ-Aminobutyric Acid Receptor Agonists Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific γ-Aminobutyric Acid Receptor Agonists Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. γ-Aminobutyric Acid Receptor Agonists Value Chain Figure 69. Manufacturing Cost Structure Figure 70. γ-Aminobutyric Acid Receptor Agonists Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • GABAA Receptors
  • GABAB Receptors
  • GABAC Receptors
Applications
  • Epilepsy
  • Anxiety
  • Neuropathic Pain
  • Insomnia
  • Other
Companies covered
  • Akorn
  • Apotex
  • CHEPLAPHARM
  • Hikma
  • Jazz Pharmaceuicals
  • Neurelis
  • SAGE Therapeutics
  • Sandoz
  • Torrent Pharma
  • Viatris
  • WG Critical Care
  • AstraZeneca
  • Changzhou Siyao Pharmaceutical
  • Fresenius Kabi
  • GSK
  • Sichuan HaiscoPharmaceuical
  • Huazhong Pharmaceutical
  • Pfizer
  • Roche
  • Mylan
  • Novartis
  • Sanofi
  • Shanghai Pharmaceuticals Holding
  • Sun Pharma
  • Teva
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global γ-Aminobutyric Acid Receptor Agonists Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global γ-Aminobutyric Acid Receptor Agonists Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global γ-Aminobutyric Acid Receptor Agonists Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global γ-Aminobutyric Acid Receptor Agonists Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global γ-Aminobutyric Acid Receptor Agonists Market Dynamics
  1. 2.1 γ-Aminobutyric Acid Receptor Agonists Industry Trends
  2. 2.2 γ-Aminobutyric Acid Receptor Agonists Industry Drivers
  3. 2.3 γ-Aminobutyric Acid Receptor Agonists Industry Opportunities and Challenges
  4. 2.4 γ-Aminobutyric Acid Receptor Agonists Industry Restraints
3 γ-Aminobutyric Acid Receptor Agonists Market by Manufacturers
  1. 3.1 Global γ-Aminobutyric Acid Receptor Agonists Revenue by Manufacturers (2021-2026)
  2. 3.2 Global γ-Aminobutyric Acid Receptor Agonists Sales by Manufacturers (2021-2026)
  3. 3.3 Global γ-Aminobutyric Acid Receptor Agonists Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global γ-Aminobutyric Acid Receptor Agonists Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global γ-Aminobutyric Acid Receptor Agonists Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global γ-Aminobutyric Acid Receptor Agonists Manufacturers, Product Type & Application
  7. 3.7 Global γ-Aminobutyric Acid Receptor Agonists Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global γ-Aminobutyric Acid Receptor Agonists Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 γ-Aminobutyric Acid Receptor Agonists Players Market Share by Revenue in 2025
  11. 3.8.3 2025 γ-Aminobutyric Acid Receptor Agonists Tier 1, Tier 2, and Tier 3
4 γ-Aminobutyric Acid Receptor Agonists Market by Type
  1. 4.1 γ-Aminobutyric Acid Receptor Agonists Type Introduction
  2. 4.1.1 GABAA Receptors
  3. 4.1.2 GABAB Receptors
  4. 4.1.3 GABAC Receptors
  5. 4.2 Global γ-Aminobutyric Acid Receptor Agonists Sales by Type
  6. 4.2.1 Global γ-Aminobutyric Acid Receptor Agonists Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global γ-Aminobutyric Acid Receptor Agonists Sales by Type (2021-2032)
  8. 4.2.3 Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Type (2021-2032)
  9. 4.3 Global γ-Aminobutyric Acid Receptor Agonists Revenue by Type
  10. 4.3.1 Global γ-Aminobutyric Acid Receptor Agonists Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global γ-Aminobutyric Acid Receptor Agonists Revenue by Type (2021-2032)
  12. 4.3.3 Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Type (2021-2032)
5 γ-Aminobutyric Acid Receptor Agonists Market by Application
  1. 5.1 γ-Aminobutyric Acid Receptor Agonists Application Introduction
  2. 5.1.1 Epilepsy
  3. 5.1.2 Anxiety
  4. 5.1.3 Neuropathic Pain
  5. 5.1.4 Insomnia
  6. 5.1.5 Other
  7. 5.2 Global γ-Aminobutyric Acid Receptor Agonists Sales by Application
  8. 5.2.1 Global γ-Aminobutyric Acid Receptor Agonists Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global γ-Aminobutyric Acid Receptor Agonists Sales by Application (2021-2032)
  10. 5.2.3 Global γ-Aminobutyric Acid Receptor Agonists Sales Market Share by Application (2021-2032)
  11. 5.3 Global γ-Aminobutyric Acid Receptor Agonists Revenue by Application
  12. 5.3.1 Global γ-Aminobutyric Acid Receptor Agonists Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global γ-Aminobutyric Acid Receptor Agonists Revenue by Application (2021-2032)
  14. 5.3.3 Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Application (2021-2032)
6 Global γ-Aminobutyric Acid Receptor Agonists Sales by Region
  1. 6.1 Global γ-Aminobutyric Acid Receptor Agonists Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global γ-Aminobutyric Acid Receptor Agonists Sales by Region (2021-2032)
  3. 6.2.1 Global γ-Aminobutyric Acid Receptor Agonists Sales by Region (2021-2026)
  4. 6.2.2 Global γ-Aminobutyric Acid Receptor Agonists Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America γ-Aminobutyric Acid Receptor Agonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America γ-Aminobutyric Acid Receptor Agonists Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe γ-Aminobutyric Acid Receptor Agonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe γ-Aminobutyric Acid Receptor Agonists Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific γ-Aminobutyric Acid Receptor Agonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific γ-Aminobutyric Acid Receptor Agonists Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global γ-Aminobutyric Acid Receptor Agonists Revenue by Region
  1. 7.1 Global γ-Aminobutyric Acid Receptor Agonists Revenue by Region
  2. 7.1.1 Global γ-Aminobutyric Acid Receptor Agonists Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global γ-Aminobutyric Acid Receptor Agonists Revenue by Region (2021-2026)
  4. 7.1.3 Global γ-Aminobutyric Acid Receptor Agonists Revenue by Region (2027-2032)
  5. 7.1.4 Global γ-Aminobutyric Acid Receptor Agonists Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America γ-Aminobutyric Acid Receptor Agonists Revenue (2021-2032)
  8. 7.2.2 North America γ-Aminobutyric Acid Receptor Agonists Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe γ-Aminobutyric Acid Receptor Agonists Revenue (2021-2032)
  11. 7.3.2 Europe γ-Aminobutyric Acid Receptor Agonists Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific γ-Aminobutyric Acid Receptor Agonists Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific γ-Aminobutyric Acid Receptor Agonists Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa γ-Aminobutyric Acid Receptor Agonists Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Akorn
  2. 8.1.1 Akorn Company Information
  3. 8.1.2 Akorn Business Overview
  4. 8.1.3 Akorn γ-Aminobutyric Acid Receptor Agonists Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Akorn γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  6. 8.1.5 Akorn Recent Developments
  7. 8.2 Apotex
  8. 8.2.1 Apotex Company Information
  9. 8.2.2 Apotex Business Overview
  10. 8.2.3 Apotex γ-Aminobutyric Acid Receptor Agonists Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Apotex γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  12. 8.2.5 Apotex Recent Developments
  13. 8.3 CHEPLAPHARM
  14. 8.3.1 CHEPLAPHARM Company Information
  15. 8.3.2 CHEPLAPHARM Business Overview
  16. 8.3.3 CHEPLAPHARM γ-Aminobutyric Acid Receptor Agonists Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 CHEPLAPHARM γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  18. 8.3.5 CHEPLAPHARM Recent Developments
  19. 8.4 Hikma
  20. 8.4.1 Hikma Company Information
  21. 8.4.2 Hikma Business Overview
  22. 8.4.3 Hikma γ-Aminobutyric Acid Receptor Agonists Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hikma γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  24. 8.4.5 Hikma Recent Developments
  25. 8.5 Jazz Pharmaceuicals
  26. 8.5.1 Jazz Pharmaceuicals Company Information
  27. 8.5.2 Jazz Pharmaceuicals Business Overview
  28. 8.5.3 Jazz Pharmaceuicals γ-Aminobutyric Acid Receptor Agonists Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Jazz Pharmaceuicals γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  30. 8.5.5 Jazz Pharmaceuicals Recent Developments
  31. 8.6 Neurelis
  32. 8.6.1 Neurelis Company Information
  33. 8.6.2 Neurelis Business Overview
  34. 8.6.3 Neurelis γ-Aminobutyric Acid Receptor Agonists Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Neurelis γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  36. 8.6.5 Neurelis Recent Developments
  37. 8.7 SAGE Therapeutics
  38. 8.7.1 SAGE Therapeutics Company Information
  39. 8.7.2 SAGE Therapeutics Business Overview
  40. 8.7.3 SAGE Therapeutics γ-Aminobutyric Acid Receptor Agonists Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 SAGE Therapeutics γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  42. 8.7.5 SAGE Therapeutics Recent Developments
  43. 8.8 Sandoz
  44. 8.8.1 Sandoz Company Information
  45. 8.8.2 Sandoz Business Overview
  46. 8.8.3 Sandoz γ-Aminobutyric Acid Receptor Agonists Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sandoz γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  48. 8.8.5 Sandoz Recent Developments
  49. 8.9 Torrent Pharma
  50. 8.9.1 Torrent Pharma Company Information
  51. 8.9.2 Torrent Pharma Business Overview
  52. 8.9.3 Torrent Pharma γ-Aminobutyric Acid Receptor Agonists Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Torrent Pharma γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  54. 8.9.5 Torrent Pharma Recent Developments
  55. 8.10 Viatris
  56. 8.10.1 Viatris Company Information
  57. 8.10.2 Viatris Business Overview
  58. 8.10.3 Viatris γ-Aminobutyric Acid Receptor Agonists Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Viatris γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  60. 8.10.5 Viatris Recent Developments
  61. 8.11 WG Critical Care
  62. 8.11.1 WG Critical Care Company Information
  63. 8.11.2 WG Critical Care Business Overview
  64. 8.11.3 WG Critical Care γ-Aminobutyric Acid Receptor Agonists Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 WG Critical Care γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  66. 8.11.5 WG Critical Care Recent Developments
  67. 8.12 AstraZeneca
  68. 8.12.1 AstraZeneca Company Information
  69. 8.12.2 AstraZeneca Business Overview
  70. 8.12.3 AstraZeneca γ-Aminobutyric Acid Receptor Agonists Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 AstraZeneca γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  72. 8.12.5 AstraZeneca Recent Developments
  73. 8.13 Changzhou Siyao Pharmaceutical
  74. 8.13.1 Changzhou Siyao Pharmaceutical Company Information
  75. 8.13.2 Changzhou Siyao Pharmaceutical Business Overview
  76. 8.13.3 Changzhou Siyao Pharmaceutical γ-Aminobutyric Acid Receptor Agonists Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Changzhou Siyao Pharmaceutical γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  78. 8.13.5 Changzhou Siyao Pharmaceutical Recent Developments
  79. 8.14 Fresenius Kabi
  80. 8.14.1 Fresenius Kabi Company Information
  81. 8.14.2 Fresenius Kabi Business Overview
  82. 8.14.3 Fresenius Kabi γ-Aminobutyric Acid Receptor Agonists Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Fresenius Kabi γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  84. 8.14.5 Fresenius Kabi Recent Developments
  85. 8.15 GSK
  86. 8.15.1 GSK Company Information
  87. 8.15.2 GSK Business Overview
  88. 8.15.3 GSK γ-Aminobutyric Acid Receptor Agonists Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 GSK γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  90. 8.15.5 GSK Recent Developments
  91. 8.16 Sichuan HaiscoPharmaceuical
  92. 8.16.1 Sichuan HaiscoPharmaceuical Company Information
  93. 8.16.2 Sichuan HaiscoPharmaceuical Business Overview
  94. 8.16.3 Sichuan HaiscoPharmaceuical γ-Aminobutyric Acid Receptor Agonists Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Sichuan HaiscoPharmaceuical γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  96. 8.16.5 Sichuan HaiscoPharmaceuical Recent Developments
  97. 8.17 Huazhong Pharmaceutical
  98. 8.17.1 Huazhong Pharmaceutical Company Information
  99. 8.17.2 Huazhong Pharmaceutical Business Overview
  100. 8.17.3 Huazhong Pharmaceutical γ-Aminobutyric Acid Receptor Agonists Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Huazhong Pharmaceutical γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  102. 8.17.5 Huazhong Pharmaceutical Recent Developments
  103. 8.18 Pfizer
  104. 8.18.1 Pfizer Company Information
  105. 8.18.2 Pfizer Business Overview
  106. 8.18.3 Pfizer γ-Aminobutyric Acid Receptor Agonists Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Pfizer γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  108. 8.18.5 Pfizer Recent Developments
  109. 8.19 Roche
  110. 8.19.1 Roche Company Information
  111. 8.19.2 Roche Business Overview
  112. 8.19.3 Roche γ-Aminobutyric Acid Receptor Agonists Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Roche γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  114. 8.19.5 Roche Recent Developments
  115. 8.20 Mylan
  116. 8.20.1 Mylan Company Information
  117. 8.20.2 Mylan Business Overview
  118. 8.20.3 Mylan γ-Aminobutyric Acid Receptor Agonists Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Mylan γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  120. 8.20.5 Mylan Recent Developments
  121. 8.21 Novartis
  122. 8.21.1 Novartis Company Information
  123. 8.21.2 Novartis Business Overview
  124. 8.21.3 Novartis γ-Aminobutyric Acid Receptor Agonists Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Novartis γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  126. 8.21.5 Novartis Recent Developments
  127. 8.22 Sanofi
  128. 8.22.1 Sanofi Company Information
  129. 8.22.2 Sanofi Business Overview
  130. 8.22.3 Sanofi γ-Aminobutyric Acid Receptor Agonists Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Sanofi γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  132. 8.22.5 Sanofi Recent Developments
  133. 8.23 Shanghai Pharmaceuticals Holding
  134. 8.23.1 Shanghai Pharmaceuticals Holding Company Information
  135. 8.23.2 Shanghai Pharmaceuticals Holding Business Overview
  136. 8.23.3 Shanghai Pharmaceuticals Holding γ-Aminobutyric Acid Receptor Agonists Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Shanghai Pharmaceuticals Holding γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  138. 8.23.5 Shanghai Pharmaceuticals Holding Recent Developments
  139. 8.24 Sun Pharma
  140. 8.24.1 Sun Pharma Company Information
  141. 8.24.2 Sun Pharma Business Overview
  142. 8.24.3 Sun Pharma γ-Aminobutyric Acid Receptor Agonists Sales, Price, Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Sun Pharma γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  144. 8.24.5 Sun Pharma Recent Developments
  145. 8.25 Teva
  146. 8.25.1 Teva Company Information
  147. 8.25.2 Teva Business Overview
  148. 8.25.3 Teva γ-Aminobutyric Acid Receptor Agonists Sales, Price, Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Teva γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  150. 8.25.5 Teva Recent Developments
  151. 8.26 Takeda
  152. 8.26.1 Takeda Company Information
  153. 8.26.2 Takeda Business Overview
  154. 8.26.3 Takeda γ-Aminobutyric Acid Receptor Agonists Sales, Price, Revenue and Gross Margin (2021-2026)
  155. 8.26.4 Takeda γ-Aminobutyric Acid Receptor Agonists Product Portfolio
  156. 8.26.5 Takeda Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 γ-Aminobutyric Acid Receptor Agonists Value Chain Analysis
  2. 9.1.1 γ-Aminobutyric Acid Receptor Agonists Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 γ-Aminobutyric Acid Receptor Agonists Production Mode & Process
  6. 9.2 γ-Aminobutyric Acid Receptor Agonists Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 γ-Aminobutyric Acid Receptor Agonists Distributors
  9. 9.2.3 γ-Aminobutyric Acid Receptor Agonists Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst